Patient-derived xenografts for investigation of acquired resistance in oncogene-driven cancers: Building a better mousetrap

Journal of Clinical Oncology

Volumn 33, Issue 26, 2015, Pages 2839-2840

  Gandara, David R ^a   Lara, Primo N ^a   Mack, Philip C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFATINIB; CETUXIMAB; ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN KINASE INHIBITOR; PROTEIN TYROSINE KINASE; TUMOR MARKER;

CANCER PATIENT; CANCER RESEARCH; CANCER RESISTANCE; EDITORIAL; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NON SMALL CELL LUNG CANCER; NONHUMAN; ONCOGENE; PATIENT DERIVED XENOGRAFT; PRIORITY JOURNAL; TREATMENT OUTCOME; TUMOR ENGRAFTMENT; TUMOR XENOGRAFT; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG RESISTANCE; FEMALE; GENETICS; LUNG TUMOR; MALE; METABOLISM; MUTATION; SIGNAL TRANSDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS; BIOMARKERS, TUMOR; CARCINOMA, NON-SMALL-CELL LUNG; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MUTATION; PROTEIN KINASE INHIBITORS; PROTEIN-TYROSINE KINASES; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION;

EID: 84964693948     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2015.61.9692     Document Type: Editorial

References (10)

1. Stewart EL, Mascaux C, Pham N-A, et al: Clinical utility of patient-derived xenografts to determine biomarkers of prognosis and map resistance pathways in EGFR-mutant lung adenocarcinoma. J Clin Oncol 33:2472-2480, 2015
2. Gandara DR, Mack PC, Bult C, et al: Bridging tumor genomics to patient outcomes through an integrated patient-derived xenograft platform. Clin Lung Cancer 16:165-172, 2015
3. DeRose YS, Wang G, Lin YC, et al: Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes. Nat Med 17:1514-1520, 2011
4. Tentler JJ, Tan AC, Weekes CD, et al: Patient-derived tumour xenografts as models for oncology drug development. Nat Rev Clin Oncol 9:338-350, 2012
5. John T, Kohler D, Pintilie M, Yanagawa N, et al: The ability to form primary tumor xenografts is predictive of increased risk of disease recurrence in early-stage non-small cell lung cancer. Clin Cancer Res 17:134-141, 2011
6. Bult CJ, Krupke DM, Begley DA, et al: Mouse Tumor Biology (MTB): A database of mouse models for human cancer. Nucleic Acids Res 43:D818-D824, 2015
7. Simpson-Abelson MR, Sonnenberg GF, Takita H, et al: Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. J Immunol 180:7009-7018, 2008
8. Hidalgo M, Bruckheimer E, Rajeshkumar NV, et al: A pilot clinical study of treatment guided by personalized tumor grafts in patients with advanced cancer. Mol Cancer Ther 10:1311-1316, 2011
9. Hidalgo M, Amant F, Biankin AV, et al: Patient-derived xenograft models: An emerging platform for translational cancer research. Cancer Discov 4:998-1013, 2014
10. Aryee KE, Schultz LD, Brehm MA: Immunodeficient mouse model for human hematopoietic stem cell engraftment and immune system development. Methods Mol Biol 1185:267-278, 2014